Efficacy of Extracorporeal Shockwave Therapy on Painful Bone Spur in Traumatic Transfemoral Amputees
1 other identifier
interventional
29
1 country
1
Brief Summary
Painful bone spur is one of the causes of residual limb pain in individuals with traumatic lower extremity amputation and can be a significant problem in rehabilitation clinics. This study aimed to investigate the effectiveness of extracorporeal shockwave therapy (ESWT) on pain and size of bone spur in traumatic transfemoral amputees with painful bone spur. Twenty nine traumatic transfemoral amputees who had painful spur were randomized into two groups: Group 1 (ESWT + therapeutic exercise) and Group 2 (sham ESWT + therapeutic exercise). The visual analog scale for pain felt in the stump at rest and during walking with the prosthesis, the lower extremity functional scale, Houghton scale, Locomotor capacity index, and radiologically determined bone spur size were used as outcome measures. All participants were evaluated before, 4 weeks after, and 12 weeks after ESWT/sham ESWT application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedFirst Submitted
Initial submission to the registry
February 12, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedFebruary 27, 2026
February 1, 2026
12 months
February 12, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
Visual Analog Scale at rest and during walking with the prosthesis. It is a 10 cm scale, that 0 demostrates no pain and 10 indicates the most unbearable pain
At baseline, 4 weeks post-application, and 12 weeks post-application
Secondary Outcomes (4)
Lower Extremity Functional Scale
At baseline, 4 weeks post-application, and 12 weeks post-application
Houghton Scale
At baseline, 4 weeks post-application, and 12 weeks post-application
Locomotor Capacity Index
At baseline, 4 weeks post-application, and 12 weeks post-application
Radiologically determined size of bone spur
At baseline, 4 weeks post-application, and 12 weeks post-application
Study Arms (2)
ESWT + therapeutic exercise
ACTIVE COMPARATORsham ESWT + therapeutic exercise
SHAM COMPARATORInterventions
Participants in Group 1 received a total of four sessions of ESWT, once a week for four consecutive weeks, with an intensity of 0.3 mj/mm2, a frequency of 4 Hz, and 1500 pulses/session
Balance-coordination and endurance-enhancing exercises, range of motion exercises, isometric and isotonic strengthening exercises were applied to patients in both groups five days a week for four weeks
Participants in Group 2 received a total of four sessions of sham ESWT, once a week for four consecutive weeks, with an intensity of 0 mj/mm2, a frequency of 4 Hz, and 1500 pulses/session
Eligibility Criteria
You may qualify if:
- unilateral transfemoral amputation due to trauma for at least 6 months
- male aged between 18 and 65
- pain in the stump region of 3 or more on the visual analog scale (VAS) for at least 1 month
- bone spur in the stump diagnosed by radiography
- failure to provide sufficient benefit from previous conservative treatment (lack of at least 50% pain reduction with analgesics and nonsteroidal anti-inflammatory drugs)
- failure to provide adequate response to socket revision
You may not qualify if:
- infection, cellulite, neuroma, fracture, skin problems that may cause pain in the stump other than bone spur
- corticosteroid injection or surgery to the stump in the last 6 months
- conditions in which the use of ESWT is contraindicated, such as bone tumors, metabolic bone problems, nerve conduction and blood circulation disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziler Physical Therapy and Rehabilitation Training and Research Hospital
Ankara, Turkey, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 12, 2026
First Posted
February 27, 2026
Study Start
March 16, 2024
Primary Completion
March 15, 2025
Study Completion
September 15, 2025
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
There should be a commitment that patient data will only be shared with the ethics committee upon request.